ClearMains
10 marks · 150 words
Practice this question
Handwrite your answer the way you would in the real exam, photograph it, and get AI-graded, rubric-based feedback — scores per dimension, strengths, gaps, and what a topper would add.
Handwrite it, get it evaluated →Want the full paper experience instead? Assemble a timed practice paper from the full GS4 question bank.
More on GS4 · Case Studies
Case Study: You are the Managing Director of "XYZ Biotech", a rapidly growing pharmaceutical firm based in India, with operations in several developing countries. Your company has recently developed a breakthrough mRNA-based vaccine for a rapidly mutating tropical disease affecting large sections of the population in Sub-Saharan Africa and parts of South Asia. The vaccine has demonstrated 94% efficacy in Phase III clinical trials and has the potential to save thousands of lives. However, the vaccine is expensive to manufacture, requiring specialized cold-chain storage, and proprietary biotechnology inputs licensed from international partners. The pricing strategy proposed by your Board is to recoup R&D investments and generate profit by pricing the vaccine at Rs. 3000 per dose, which makes it unaffordable for many low-income populations in target regions. Meanwhile, several NGOs, global health organizations, and even a few governments are urging you to waive your patent rights, or adopt tiered pricing to allow cheaper versions or voluntary licensing for public-sector manufacture. You are also under pressure from investors, who expect high returns due to the innovation. Some stakeholders suggest cutting costs by outsourcing trials to countries with weaker regulatory standards, while others propose delaying access in poorer countries to focus on wealthier clients first. Your own conscience is conflicted—you believe in public health as a right, but also have obligations to shareholders, employees, and long-term sustainability of the firm. a) Identify and discuss the ethical issues involved in this case. b) What would be your immediate response to the situation described above? c) If a global health coalition asks for voluntary licensing of your vaccine, how would you respond both ethically and strategically? d) As a conscientious public-spirited executive, suggest a balanced strategy that ensures innovation, affordability, and ethical integrity.
The government under PM Awas yojana has promised to provide affordable housing to the urban poor. However, after the inspection, it was found that there is a shortage of residential plots in the city. You as the District Magistrate have requested the government to release some vacant public land for the construction of houses under this scheme. While accepting the proposal, the concerned minister suggests that 20% of houses should be allotted from his discretionary quota. In this situation, you have the following options: 1. Simply follow the orders of the minister. 2. Tell the minister that the proposed discretionary allotments will lead to serious controversy. 3. Delay the matter. 4. Oppose the decision tooth and nail. Analyze these options and what advice you would have given to the minister?